P. Moerloose

发表

NF‐κB is activated from endosomal compartments in antiphospholipid antibodies‐treated human monocytes

E. Kruithof, K. Brandt, C. Fickentscher, 2014, Journal of thrombosis and haemostasis : JTH.

Resistance to activated protein C in an unselected population of patients with pulmonary embolism

P. Moerloose, H. Bounameaux, A. Perrier, 1996, The Lancet.

Hypertension, haematuria and renal functioning in haemophilia – a cross‐sectional study in Europe

C. Combescure, R. Tait, P. Holme, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of venous thromboembolism

C. Samama, P. Moerloose, S. Motte, 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Standardization of D‐dimer Testing

P. Moerloose, G. Reber, 2013 .

Should neurologists measure D-dimer concentrations?

F. Boehlen, P. Moerloose, 2003, The Lancet Neurology.

Non-invasive diagnosis of venous thromboembolism in outpatients

D. Slosman, D. Didier, P. Moerloose, 1999, The Lancet.

Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients

D. Slosman, D. Didier, P. Moerloose, 1999 .

A lipid associated with the antiphospholipid syndrome regulates endosome structure and function

R. Parton, Toshihide Kobayashi, E. Stang, 1998, Nature.

IMMUNOHISTOLOGICAL ANALYSIS OF SERIAL BIOPSIES TAKEN DURING HUMAN RENAL ALLOGRAFT REJECTION: CHANGING PROFILE OF INFILTRATING CELLS AND ACTIVATION OF THE COAGULATION SYSTEM

R. Atkins, W. Hancock, P. Moerloose, 1985, Transplantation.

Preoperative hemostatic assessment: a new and simple bleeding questionnaire

F. Boehlen, P. Moerloose, F. Clergue, 2016, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 Antibodies

E. Kruithof, P. Moerloose, P. de Moerloose, 2002, Thrombosis and Haemostasis.

Can the phenotype of inherited fibrinogen disorders be predicted?

A. Casini, P. Moerloose, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients

P. Moerloose, G. Reber, P. Merlani, 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Proceedings of the European Symposium on Strategies in Diagnosis of Venous Thromboembolism, June 18, 1999 Utrecht, The Netherlands

P. Moerloose, H. M.C., K. Hamuly, 1999 .

DIAGNOSTIC VALUE OF PLASMA D-DIMER IN SUSPECTED PULMONARY EMBOLISM

D. Slosman, P. Moerloose, H. Bounameaux, 1988, The Lancet.

Anticoagulation orale: attitudes pratiques

P. Moerloose, W. Wuillemin, A. Niederer, 2001 .

Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study

T. Perneger, J. Gris, J. Daurès, 2002, The Lancet.

closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis

M. Dauzat, P. Fontana, P. Moerloose, 2008 .

LETTERS TO THE EDITOR: Performances of the HemosIL D‐dimer HS assay for the exclusion of venous thromboembolism

J. Arnout, P. Moerloose, G. Reber, 2005, Journal of thrombosis and haemostasis : JTH.

D-dimer assays for the exclusion of venous thromboembolism: which test for which diagnostic strategy?

P. Moerloose, 2000 .

Mécanismes d’activation cellulaire par les anticorps antiphospholipides

E. Kruithof, P. Moerloose, G. Reber, 2008 .

[Thrombophilia: which tests in 2012?].

A. Casini, F. Boehlen, P. Moerloose, 2012, La Revue de medecine interne.

Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature

P. Fontana, F. Boehlen, P. Moerloose, 2004, BJOG : an international journal of obstetrics and gynaecology.

Intensive Care Point of care and central laboratory determina-tions of the aPTT are not interchangeable in surgical intensive care patients

P. Moerloose, G. Reber, P. Merlani, 2008 .

Variability of anti-β2 glycoprotein I antibodies measurement by commercial assays

A. Tincani, P. Moerloose, P. de Moerloose, 2005, Thrombosis and Haemostasis.

Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature

C. Sokollik, S. Lukowski, A. Casini, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Pertussigen enhances antigen-driven interferon-γ production by sensitized lymphoid cells

M. Vadas, W. Sewell, J. McKimm-Breschkin, 1986 .

Rofecoxib interaction with oral anticoagulant acenocoumarol

J. Desmeules, M. Siegenthaler, P. Moerloose, 2003, European Journal of Clinical Pharmacology.

One Hundred Years of Congenital Fibrinogen Disorders.

A. Casini, P. Moerloose, M. Neerman-Arbez, 2022, Seminars in thrombosis and hemostasis.

Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management

A. Casini, P. Moerloose, 2016 .

Congenital combined deficiency of coagulation factors VII and X – different genetic mechanisms

J. Oldenburg, A. Pavlova, J. Driesen, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Antiphospholipid antibodies and the risk of severe and non‐severe pre‐eclampsia: the NOHA case‐control study

J. Gris, P. Moerloose, T. Marchetti, 2016, Journal of thrombosis and haemostasis : JTH.

Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management

A. Casini, P. Moerloose, M. Neerman-Arbez, 2015, Journal of thrombosis and haemostasis : JTH.

Minimizing perioperative blood loss and transfusions in children

P. Moerloose, J. Guay, D. Lasne, 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Activated protein C and pulmonary embolism

J. Piette, I. Roberts, Z. Amoura, 1996, The Lancet.

Improving haemophilia patient care through sharing best practice

P. Moerloose, B. O’Mahony, Brian Colvin, 2015, European journal of haematology.

Transfusion massive et coagulopathie-: physiopathologie et implications cliniques

C. Samama, P. Moerloose, J. Hardy, 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Laboratory evaluation of hemostasis before cardiac operations.

P. Moerloose, 1996 .

Outcome measures in European patients with haemophilia

C. Hermans, R. Klamroth, M. Richards, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia – an assessment by the ADVANCE Working Group

G. Dolan, R. Schutgens, P. Moerloose, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Novel products for haemostasis

C. Hermans, M. Shima, P. Moerloose, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of Acute Haemarthrosis in Haemophilia: a European Survey

G. Dolan, R. Hermans, K. Fischer, 2009 .

Cancer detection and management in patients with haemophilia: a retrospective European multicentre study

C. Hermans, C. Biron-Andréani, H. Chambost, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Orthotopic liver transplantation in hemophilia B: a case report

P. Morel, G. Mentha, H. Blum, 1995, Transplant international : official journal of the European Society for Organ Transplantation.

Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders

C. Rothschild, R. Lassila, R. Pérez, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Letters to the

F. Boehlen, P. Moerloose, G. Reber, 1997 .

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

C. Wuillemin, P. Moerloose, A. Ruffatti, 2014, Journal of thrombosis and haemostasis : JTH.

Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial

J. Gris, S. Bouvet, P. Fabbro-Péray, 2015, Journal of thrombosis and haemostasis : JTH.

Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism

D. Slosman, P. Unger, P. Moerloose, 1991, The Lancet.

Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation

A. Casini, P. Moerloose, M. Neerman-Arbez, 2017, Journal of thrombosis and haemostasis : JTH.

Fibrinogen Krakow: A novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function

E. Stępień, A. Skotnicki, P. Moerloose, 2009, Thrombosis and Haemostasis.

Severe Neonatal Alloimmune Thrombocytopenia due to Anti‐HPA‐3a

C. Kaplan, F. Boehlen, P. Moerloose, 1998 .

Should the D-dimer Cut-off Value Be Increased in Elderly Patients Suspected of Pulmonary Embolism?

P. Moerloose, P. de Moerloose, H. Bounameaux, 2001, Thrombosis and Haemostasis.

Massive transfusion and coagulopathy: pathophysiology and implications for clinical management

C. Samama, P. Moerloose, J. Hardy, 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Interaction of antiphospholipid antibodies with late endosomes of human endothelial cells.

M. Lindsay, R. Parton, E. Kruithof, 1999 .

Acquired factor XIII deficiency: a therapeutic challenge

A. Casini, C. Chizzolini, F. Boehlen, 2013, Thrombosis and Haemostasis.

Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients

C. Combescure, Jean-Charles Sanchez, P. Fontana, 2011, Thrombosis and Haemostasis.

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery

M. Boulvain, F. Boehlen, P. Moerloose, 2009, Thrombosis and Haemostasis.

Plasma soluble fibrin monomer complex is a useful predictor of disseminated intravascular coagulation in neonatal sepsis

F. Boehlen, P. Moerloose, M. Neerman-Arbez, 2005 .

Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH

J. Thachil, A. Casini, R. Palla, 2018, Journal of thrombosis and haemostasis : JTH.

Management of congenital quantitative fibrinogen disorders: a Delphi consensus

A. Casini, P. Moerloose, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Performances of the Fibrin Monomer Test for the Exclusion of Pulmonary Embolism in Symptomatic Outpatients

P. Moerloose, H. Bounameaux, A. Perrier, 1999, Thrombosis and Haemostasis.

Point of care management of heparin administration after heart surgery

P. Garnerin, P. Moerloose, G. Reber, 2006, Intensive Care Medicine.

Inflammatory and Prothrombotic States in Obese Children of European Descent

C. Combescure, P. Roux‐Lombard, C. Meier, 2012, Obesity.

Spuriously Low Levels of Protein C with a Protac® Activation Clotting Assay

P. Moerloose, G. Reber, C. Bouvier, 1988, Thrombosis and Haemostasis.

Aspirin "resistance" and risk of cardiovascular morbidity

J. Gris, P. Fontana, J. Reny, 2008 .

Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti–beta2 glycoprotein‐1 antibodies

P. Fontana, A. Poncet, P. Moerloose, 2014, Journal of thrombosis and haemostasis : JTH.

A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system

P. Fontana, A. Poncet, J. Musial, 2017, Journal of thrombosis and haemostasis : JTH.

Anti-β2-glycoprotein I ELISA assay: The influence of different antigen preparations

P. Moerloose, G. Reber, A. Ruffatti, 2009, Thrombosis and Haemostasis.

Anticorps anticardiolipine et thromboses

P. Moerloose, C. Bernard, 1990 .

Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis

A. Lebreton, A. Casini, P. Moerloose, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Rare coagulation disorders: fibrinogen, factor VII and factor XIII

J. Schved, P. Moerloose, D. Nugent, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

FXI concentrate use and risk of thrombosis

C. Hermans, M. Makris, J. Goudemand, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique

J. Desmeules, P. Moerloose, P. Dayer, 2007 .

Superficial Vein Thrombosis of Lower Limbs: Influence of Factor V Leiden, Factor II G20210A and Overweight

T. Perneger, P. Moerloose, P. de Moerloose, 1998, Thrombosis and Haemostasis.

Value of Liquid Crystal Contact Thermography and Plasma Level of D-Dimer for Screening of Deep Venous Thrombosis Following General Abdominal Surgery

O. Huber, D. Didier, P. Moerloose, 1992, Thrombosis and Haemostasis.

Coagulation disorders and thrombosis

S. Bélisle, C. Samama, Y. Ozier, 1999 .

Mise au point Transfusion massive et dysfonction hémostatique : physiopathologie et gestion clinique Massive transfusion and coagulopathy : pathophysiology and implications for clinical management

C. Samama, P. Moerloose, J. Hardy, 2004 .

Anticardiolipin Antibodies in Acute Venous Thromboembolism

P. Moerloose, H. Bounameaux, G. Reber, 1992, Thrombosis and Haemostasis.

Association of Red-blood Methylfolate but not Plasma Folate with C677T MTHFR Polymorphism in Venous Thromboembolic Disease

G. Assmann, J. Gris, D. Nabavi, 1998, Thrombosis and Haemostasis.

Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob ‘A’

J. Weisel, C. Biron-Andréani, P. Moerloose, 2010, Thrombosis and Haemostasis.

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery

M. Boulvain, F. Boehlen, P. Moerloose, 2009, Thrombosis and Haemostasis.

Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower-limb venous compression ultrasonography?

D. Slosman, D. Didier, P. Unger, 2000, Archives of Internal Medicine.

The coagulopathy of massive transfusion

C. Samama, P. Moerloose, P. de Moerloose, 2005, Vox sanguinis.

Clinical management of older persons with haemophilia.

C. Hermans, G. Dolan, P. Moerloose, 2014, Critical reviews in oncology/hematology.

D‐Dimer for venous thromboembolism diagnosis: 20 years later

P. Moerloose, P. de Moerloose, H. Bounameaux, 2008, Journal of thrombosis and haemostasis : JTH.

Management of venous thromboembolism

C. Samama, P. Moerloose, S. Motte, 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism.

P. Moerloose, P. de Moerloose, H. Bounameaux, 1993, Thrombosis research.

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

F E Preston, P G Mori, S S Sommer, 1995, Blood.

Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteers

P. Fontana, P. Moerloose, P. de Moerloose, 2006, Journal of thrombosis and haemostasis : JTH.

A new, semi-quantitative and individual ELISA for rapid measurement of plasma D-dimer in patients suspected of pulmonary embolism.

J. Amiral, P. Moerloose, P. de Moerloose, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

mutation in FGB impairing fibrinogen secretion Congenital afibrinogenemia: identification and expression of a missense

J. Parr, M. Morris, P. Bolton-Maggs, 2013 .

surveillance mechanisms in transfected cells responsible for congenital afibrinogenemia: escape from RNA Expression and analysis of a split premature termination codon in FGG

S. Deutsch, M. Morris, P. Moerloose, 2004 .

Brief report Congenital aﬁbrinogenemia: identiﬁcation and expression of a missense mutation in FGB impairing ﬁbrinogen secretion

J. Parr, M. Morris, P. Bolton-Maggs, 2003 .

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

P. D. de Groot, T. Kveder, J. Rand, 2009, Journal of thrombosis and haemostasis : JTH.

Rare bleeding disorders

F. Peyvandi, P. Moerloose, P. de Moerloose, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Proposals for the measurement of anti‐β2‐glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies

A. Tincani, P. Moerloose, P. de Moerloose, 2004, Journal of thrombosis and haemostasis : JTH.

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.

F. Sarasin, P. Moerloose, P. de Moerloose, 2000, Archives of internal medicine.

Cost-effectiveness of noninvasive diagnostic aids in suspected pulmonary embolism.

D. Slosman, A. Morabia, D. Didier, 1997, Archives of internal medicine.

Plasma Measurement of D-Dimer as Diagnostic Aid in Suspected Venous Thromboembolism: An Overview

P. Moerloose, P. de Moerloose, H. Bounameaux, 1994, Thrombosis and Haemostasis.

How and when to monitor a patient treated with low molecular weight heparin.

B. Boneu, P. Moerloose, P. de Moerloose, 2001, Seminars in thrombosis and hemostasis.

Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies

E. Kruithof, F. Boehlen, P. Moerloose, 2004, Journal of thrombosis and haemostasis : JTH.

Lack of Association Between Antiphospholipid Antibodies and Migraine

L. Kappos, P. Moerloose, P. de Moerloose, 1993, Thrombosis and Haemostasis.

Multicenter Evaluation of Nine Commercial Kits for the Quantitation of Anticardiolipin Antibodies

P. Moerloose, P. de Moerloose, G. Reber, 1995, Thrombosis and Haemostasis.

Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome

J. Musial, J. Arnout, J. Arnout, 2010, Journal of thrombosis and haemostasis : JTH.

D-dimer testing in suspected venous thromboembolism: an update.

P. Moerloose, P. de Moerloose, H. Bounameaux, 1997, QJM : monthly journal of the Association of Physicians.

Use of the PFA‐100™ closure time to predict cardiovascular events in aspirin‐treated cardiovascular patients: a systematic review and meta‐analysis

M. Dauzat, P. Fontana, J. Reny, 2008, Journal of thrombosis and haemostasis : JTH.

A survey of adherence to haemophilia therapy in six European countries: results and recommendations

H. M. van den Berg, M. Richards, P. Moerloose, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study.

D. Slosman, A. Morabia, D. Didier, 1996, Archives of internal medicine.

Letters to the

K. Parker, E. Carstensen, F. Boehlen, 1997 .

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

C. Hermans, G. Dolan, H. Chambost, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Anti‐protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation

T. Lecompte, F. Boehlen, P. Moerloose, 2005, Journal of thrombosis and haemostasis : JTH.

Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy.

O. Huber, D. Didier, P. Moerloose, 1997, Thrombosis research.

Inflammatory and Prothrombotic States in Obese Children of European Descent

C. Combescure, P. Roux‐Lombard, C. Meier, 2012, Obesity.

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

P. Moerloose, A. Ruffatti, Marie Cohen, 2014, Journal of thrombosis and haemostasis : JTH.

Invitation to a debate on the serological criteria that define the antiphospholipid syndrome

P. Moerloose, P. de Moerloose, G. Reber, 2008, Journal of thrombosis and haemostasis : JTH.

Use of the PFA‐100™ closure time to predict cardiovascular events in aspirin‐treated cardiovascular patients: a systematic review and meta‐analysis

M. Dauzat, P. Fontana, J. Reny, 2008, Journal of thrombosis and haemostasis : JTH.

Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome.

T. Fuchs-Buder, P. Suter, J. Romand, 1996, American journal of respiratory and critical care medicine.

von Willebrand factor: from cell biology to the clinical management of von Willebrand’s disease

U. Vischer, P. Moerloose, P. de Moerloose, 1999 .

The role of prophylaxis in bleeding disorders

R. Ljung, E. Berntorp, P. Moerloose, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

D‐dimer levels during delivery and the postpartum

M. Boulvain, F. Boehlen, P. Moerloose, 2005, Journal of thrombosis and haemostasis : JTH.

Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism

T. Perneger, P. Moerloose, P. de Moerloose, 2000, British journal of haematology.

Is measurement of d-dimer useful in the diagnosis of cerebral venous thrombosis?

K. Lovblad, K. Lövblad, F. Sarasin, 2003, Neurology.

Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia.

P. Hohlfeld, F. Boehlen, P. Moerloose, 1999, Obstetrics and gynecology.

Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients.

E. de Benedetti, P. Moerloose, P. de Moerloose, 1992, The European respiratory journal.

Radioimmunoassay of bromperidol and haloperidol in human and canine plasma

P. Moerloose, M. Bogaert, F. Belpaire, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?

P. Moerloose, P. de Moerloose, G. Reber, 2004, Journal of thrombosis and haemostasis : JTH.

Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?

P. Fontana, J. Reny, P. Moerloose, 2009, Journal of thrombosis and haemostasis : JTH.

Hemostatic Disturbances Induced by Two Hollow-Fiber Hemodialysis Membranes

P. Moerloose, P. de Moerloose, G. Reber, 1992, The International journal of artificial organs.

Comparison of Two Hemodialysis Membranes, Polyacrilonitrile and Cellulose Acetate, on Complement and Coagulation Systems

P. Moerloose, P. de Moerloose, G. Reber, 1990, The International journal of artificial organs.

Clinical management of older persons with haemophilia.

C. Hermans, G. Dolan, P. Moerloose, 2014, Critical reviews in oncology/hematology.

Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation

L. Vadas, P. Moerloose, P. de Moerloose, 2002, European Respiratory Journal.

Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects

J. Hulot, P. Fontana, P. Moerloose, 2007, Journal of thrombosis and haemostasis : JTH.

Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders.

P. Moerloose, M. Neerman-Arbez, Alessandro Casini, 2024, Seminars in thrombosis and hemostasis.

Haemostatic disorders during liver transplantation

N. Nathan, Y. Ozier, P. Moerloose, 2001, European journal of anaesthesiology.

Plasma D-dimer in suspected pulmonary embolism: a comparison with pulmonary angiography and ventilation--perfusion scintigraphy.

D. Slosman, P. Moerloose, P. de Moerloose, 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization

A. Casini, P. Moerloose, P. de Moerloose, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants.

M. Migaud, P. Moerloose, P. de Moerloose, 1994, Thrombosis research.

Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A

P. Moerloose, C. Gardiner, O. Jd, 2011 .

Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.

M. Lindsay, R. Parton, E. Kruithof, 1999, Arteriosclerosis, thrombosis, and vascular biology.